Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats

Gene Therapy

Volumn 13, Issue 16, 2006, Pages 1214-1221

  Reggiani, P C ^a   Herenu C B ^a   Rimoldi, O J ^a   Brown, O A ^a   Pleau J M ^b   Dardenne, M ^b   Goya, R G ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; THYMULIN; THYMUS SERUM FACTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN BHK; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA SEQUENCE; ENCEPHALITIS; EXPRESSION VECTOR; FEMALE; GENE THERAPY; GENETIC TRANSFECTION; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEQUENCE ANALYSIS; THYMECTOMY;

ADENOVIRIDAE; ANIMALS; CELL LINE; CELL NUCLEUS; CRICETINAE; CYTOPLASM; ENCEPHALITIS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; THYMECTOMY; THYMIC FACTOR, CIRCULATING; TIME FACTORS;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 33746871159     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302775     Document Type: Article

References (27)

1. Bach JF, Dardenne M, Pléau JM, Rosa J. Biochemical characterization of a serum thymic factor. Nature 1977; 266: 55-57.
2. Bach JF. Thymulin (FTS-Zn). Clin Immunol Allergy 1983; 3: 133-156.
3. Gastinel LN, Dardenne M, Pléau JM, Bach JF. Studies on the zinc-binding site to the serum thymic factor. Biochim Biophys Acta 1984; 797: 147-155.
4. Dardenne M, Pléau JM, Nabarra B, Lefrancier P, Derrien M, Choay J et al. Contribution of zinc and other metals to the biological activity of serum thymic factor (FTS). Proc Natl Acad Sci USA 1982; 79: 5370-5373.
5. Cung MT, Marraud M, Lefrancier P, Dardenne M, Bach JF, Laussac JP. NMR study of a lymphocyte differentiating thymic factor. J Biol Chem 1988; 263: 5574-5580.
6. Goya RG, Brown OA, Pléau JM, Dardenne M. Thymulin and the neuroendocrine system. Peptides 2004; 25: 139-142.
7. Safieh-Garabedian B, Dardenne M, Pleau JM, Saadé NE. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Br J Pharmacol 2002; 136: 947-955.
8. Safieh-Garabedian B, Ochoa-Chaar CI, Poole S, Massaad CA, Atweh SF, Jabbur SJ et al. Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v endotoxin injection. Neuroscience 2003; 121: 865-873.
9. Goya RG, Cónsole GM, Hereñú CB, Brown OA, Rimoldi OJ. Thymus and aging: Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models. Gerontology 2002; 48: 325-328.
10. http://www.kazusa.or.jp/codon/.
11. http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi?mode=c.
12. Calenda A, Cordonnier A, Lederer F, Le DKH, Pléau JM. Production of biologically active thymulin in Escherichia coli through expression of a chemically synthesized gene. Biotechnol Lett 1988; 10: 155-160.
13. Wan YP, Folkers K. Synthesis of the facteur thymique sérique and an analogue also related to thymopoietin. Bioorganic Chem 1979; 8: 35-39.
14. Imaizumi A, Gyotoku J, Terada S, Kimoto E. Structural requirement for the biological activity of serum thymic factor. FEBS Lett 1981; 128: 108-110.
15. Bach JF, Dardenne M. Thymic hormones in immunological diseases. Immunol Allergy Pract 1984; 6: 15-20.
16. Schmitt D, Monier JC, Dardenne M, Pleau JM, Deschaux P, Bach JF. Cytoplasmic localization of FTS (Facteur Thymique Serique) in thymic epithelial cells. An immunoelectron-microscopical study. Thymus 1980; 2: 177-186.
17. Auger C, Monier JC, Savino W, Dardenne M. Localization of thymulin (FTS-Zn) in mouse thymus. Comparative data using monoclonal antibodies following different plastic embedding procedures. Biol Cell 1984; 52: 139-146.
18. Savino W, Dardenne M. Thymic hormone-containing cells. VIII. Effects of colchicine, cytochalasin B, and monensin on secretion of thymulin by cultured human thymic epithelial cells. J Histochem Cytochem 1986; 34: 1719-1723.
19. Rivera VM, Ye X, Courage NL, Sachar J, Cerasoli Jr F, Wilson JM et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci USA 1999; 96: 8657-8662.
20. Marshall DJ, Leiden JM. Recent advances in skeletal-muscle-based gene therapy. Curr Opin Genet Dev 1998; 8: 360-365.
21. Bach JF, Dardenne M, Goldstein AL. Clinical Aspects of thymulin (FTS). In: Goldstein AL (ed). Thymic Hormones and Lymphokines. Basic Chemistry and Clinical Applications. Plenum Press: New York, 1984, pp. 593-600.
22. The Biological Council Animal Research & Welfare Panel. Guidelines on Handling and Training of Laboratory Animals. UFAW: Perth, 1992.
23. Kasahara S, Itoh T. Separation and characterization of rat thymocyte subpopulations. Thymus 1985; 7: 301-316.
24. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 2001.
25. Hitt M, Bett A, Prevec L, Graham FL. Construction and propagation of human adenovirus vectors. In: Celis J (ed). Cell Biology: A Laboratory Handbook. Academic Press: New York, 1998, pp. 1500-1512.
26. Dardenne M, Bach JF. The sheep cell rosette assay for the evaluation of thymic hormones. In: Van Bekkum DW, Kruisbeek AM (eds). Biological Activity of Thymic Hormones. International Workshop and Symposium. Kooyker Scientific Publications. Halsted Press Division, Wiley: Rotterdam, Netherlands, 1975, pp. 235-243.
27. Metreau E, Pléau JM, Dardenne M, Bach JF, Pradelles P. An enzyme immunoassay for synthetic thymulin. J Immunol Meth 1987; 102: 233-242.